// App-Quantinova.ai

181 : Dynamic changes in biomarkers for immune response to sipuleucel-t (SipT) for metastatic castrate-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Mehmet Faith Hepgur

Principal Investigators

  • Tanya B. Dorff

  • David I. Quinn

  • Jie Cai

  • Mary Reed

  • Betty Chan

Medical Centers

  • Institute of Urology, University of Southern California, Los Angeles, CA

  • Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CAUSC Norris Comprehensive Cancer Center, Los Angeles, CAUSC Norris Comprehensive Cancer Center and Hospital, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Amyloid P compound, Serum

  • C reactive protein

  • Circulating tumor cells

  • Prostate specific antigen

  • Prostatic acid phosphatase

  • Human albumin

  • Intercellular adhesion molecule 1

  • Lactate dehydrogenase

  • Tenascin-C

Drug/Treatment

  • Alkaline phosphatase

  • Sipuleucel-T

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved